OptimizeRx (OPRX) Change in Acquisitions & Divestments (2023)
OptimizeRx recorded quarterly Change in Acquisitions & Divestments of $53.6 million in Q4 2023, up 1.96% quarter-over-quarter from $52.6 million in Q3 2023.
OptimizeRx's Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at $53.6 million for Q4 2023.
- In Q4 2023, Change in Acquisitions & Divestments changed N/A year-over-year to $53.6 million; the TTM figure through Dec 2023 stood at $218.7 million (changed N/A YoY), while the FY2023 annual figure was $218.7 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments came in at $53.6 million for Q4 2023 at OptimizeRx, up from $52.6 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $56.9 million in Q2 2023 to a low of $52.6 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | OptimizeRx | 101.31 Mn | 81.14 Mn | 15.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 53.62 Mn |
| Dec 31, 2023 | 53.62 Mn |
| Sep 30, 2023 | 52.59 Mn |
| Sep 30, 2023 | 52.59 Mn |
| Jun 30, 2023 | 56.90 Mn |
| Jun 30, 2023 | 56.90 Mn |
| Mar 31, 2023 | 55.60 Mn |
| Mar 31, 2023 | 55.60 Mn |